Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio.
Details
Serval ID
serval:BIB_22B215888B2C
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Institution
Title
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio.
Journal
Gastroenterology
Working group(s)
French Fecal Transplant Group
Contributor(s)
Benech N., Cassir N., Alric L., Melchior C., Mosca A., Joly A.C., Kapel N., Barbut F., Galperine T., Pigneur B., Davido B., Schneider S., Briot T., Wasiak M., Nebad B., Batista R., Mosca A., Bleibtreu A., Scanzi J., Sokol H., Sintes R., Corriger A., Flet L., Perlemuter G., Ahloulay M., Yaye H.S., De Rougemont A., Olivier E., Burucoa C., Gobert J.G., Landman C., Vignal L., Joly F., Ravinet A., Bellanger A., Sabate J.M., Humbert C., Wisnewsky J.A., Charpentier C., Moreno-Sabater A., Takoudju C., Poirier P., Tanne F., De Lastours V., Stampfli C.
ISSN
1528-0012 (Electronic)
ISSN-L
0016-5085
Publication state
Published
Issued date
08/2024
Peer-reviewed
Oui
Volume
167
Number
3
Pages
627-628
Language
english
Notes
Publication types: Journal Article ; Case Reports ; Letter
Publication Status: ppublish
Publication Status: ppublish
Keywords
Humans, Fecal Microbiota Transplantation/adverse effects, Immunocompromised Host, Clostridium Infections/therapy, Clostridium Infections/diagnosis, Clostridium Infections/microbiology, Clostridium Infections/immunology, Clostridioides difficile, Risk Assessment, Recurrence, Male, Female, Treatment Outcome, Middle Aged, Aged
Pubmed
Web of science
Open Access
Yes
Create date
03/05/2024 15:12
Last modification date
20/08/2024 7:23